Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
The Adult Leukemia Program is part of the Hematologic Oncology (Blood Cancers) Treatment Center. Our specialists are highly experienced
in treating patients with acute and chronic leukemia, myeloproliferative disorders and myelodysplastic syndromes.
The Adult Leukemia Program provides care for patients with leukemia, such as
acute myeloid leukemia (AML),
acute lymphoblastic leukemia (ALL),
chronic myelogenous leukemia (CML), and related bone marrow disorders, including myelodysplasia and myelofibrosis. Our program is one of the most
experienced in the nation, with a high volume of consultations, patients cared for, and clinical trials offered. Through our program of clinical research, we apply our ongoing understanding of leukemia to developing therapies that will benefit patients
today and in the future.
The Adult Leukemia Program provides comprehensive services for patients with acute leukemia and related disorders. These include:
New Patient Appointments
Clinical Trials Questions?
As a new Dana-Farber patient, find answers to questions about your first visit: what to bring, how to find us, where to park, and how to prepare.
We offer a wide range of services, from financial planning to creative arts to spiritual counsel, to support our patients through their cancer experiences.
See patient satisfaction survey results for different Dana-Farber locations collected by Press Ganey, an independent company experienced in patient satisfaction surveying.